Healthcare provider profile · identity verified

Shawn Steiner, ARNP

Nurse Practitioner · FORT MYERS, FL · NPI 1861770042

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	245	92
Losartan Potassium	Losartan Potassium	208	64
Atorvastatin Calcium	Atorvastatin Calcium	181	67
Levothyroxine Sodium	Levothyroxine Sodium	178	61
Rosuvastatin Calcium	Rosuvastatin Calcium	170	57
Lisinopril	Lisinopril	162	53
Omeprazole	Omeprazole	107	29
Hydrochlorothiazide	Hydrochlorothiazide	105	33
Gabapentin	Gabapentin	96	36
Simvastatin	Simvastatin	86	26
Metoprolol Succinate	Metoprolol Succinate	78	32
Pantoprazole Sodium	Pantoprazole Sodium	74	27
Trazodone Hcl	Trazodone Hcl	72	21
Pravastatin Sodium	Pravastatin Sodium	57	17
Doxycycline Hyclate	Doxycycline Hyclate	55	55
Sertraline Hcl	Sertraline Hcl	55	19
Allopurinol	Allopurinol	54	18
Methylprednisolone	Methylprednisolone	54	53
Metformin Hcl Er	Metformin Hcl	52	18
Metformin Hcl	Metformin Hcl	51	19
Ozempic	Semaglutide	50	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	47	21
Ezetimibe	Ezetimibe	47	18
Potassium Chloride	Potassium Chloride	43	12
Montelukast Sodium	Montelukast Sodium	42	15
Glimepiride	Glimepiride	37	13
Azithromycin	Azithromycin	36	33
Escitalopram Oxalate	Escitalopram Oxalate	35	suppressed
Alendronate Sodium	Alendronate Sodium	34	12
Citalopram Hbr	Citalopram Hydrobromide	34	13
Metoprolol Tartrate	Metoprolol Tartrate	33	13
Eliquis	Apixaban	31	11
Hydralazine Hcl	Hydralazine Hcl	31	14
Mirtazapine	Mirtazapine	31	suppressed
Buspirone Hcl	Buspirone Hcl	30	17
Furosemide	Furosemide	30	suppressed
Bupropion Xl	Bupropion Hcl	29	suppressed
Clopidogrel	Clopidogrel Bisulfate	29	suppressed
Carvedilol	Carvedilol	25	13
Fluticasone Propionate	Fluticasone Propionate	25	11
Propranolol Hcl	Propranolol Hcl	24	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	24	suppressed
Atenolol	Atenolol	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Torsemide	Torsemide	22	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Duloxetine Hcl	Duloxetine Hcl	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	21
Xarelto	Rivaroxaban	19	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Famotidine	Famotidine	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	16
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Prolia	Denosumab	16	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	14
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	14	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Alprazolam	Alprazolam	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Meloxicam	Meloxicam	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Jardiance	Empagliflozin	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Risedronate Sodium	Risedronate Sodium	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error